GB9810193D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB9810193D0
GB9810193D0 GBGB9810193.4A GB9810193A GB9810193D0 GB 9810193 D0 GB9810193 D0 GB 9810193D0 GB 9810193 A GB9810193 A GB 9810193A GB 9810193 D0 GB9810193 D0 GB 9810193D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9810193.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GBGB9810193.4A priority Critical patent/GB9810193D0/en
Publication of GB9810193D0 publication Critical patent/GB9810193D0/en
Application status is Ceased legal-status Critical

Links

GBGB9810193.4A 1998-05-12 1998-05-12 Novel compounds Ceased GB9810193D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB9810193.4A GB9810193D0 (en) 1998-05-12 1998-05-12 Novel compounds

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9810193.4A GB9810193D0 (en) 1998-05-12 1998-05-12 Novel compounds
PCT/EP1999/003262 WO1999058562A2 (en) 1998-05-12 1999-05-10 Novel compounds
EP19990950345 EP1086127A1 (en) 1998-05-12 1999-05-10 Novel compounds
CA 2328061 CA2328061A1 (en) 1998-05-12 1999-05-10 Novel compounds
AU42601/99A AU4260199A (en) 1998-05-12 1999-05-10 Novel compounds

Publications (1)

Publication Number Publication Date
GB9810193D0 true GB9810193D0 (en) 1998-07-08

Family

ID=10831938

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9810193.4A Ceased GB9810193D0 (en) 1998-05-12 1998-05-12 Novel compounds

Country Status (5)

Country Link
EP (1) EP1086127A1 (en)
AU (1) AU4260199A (en)
CA (1) CA2328061A1 (en)
GB (1) GB9810193D0 (en)
WO (1) WO1999058562A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
EP2277595A3 (en) 2004-06-24 2011-09-28 Novartis Vaccines and Diagnostics, Inc. Compounds for immunopotentiation
JP2009511636A (en) 2005-10-18 2009-03-19 ノバルティス ヴァクシンズ アンド ダイアグノスティクス, インコーポレイテッド Mucosal and systemic immunity with alphavirus replicon particles
JP5215865B2 (en) 2005-11-22 2013-06-19 ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド Norovirus and sapovirus antigens
WO2008019162A2 (en) 2006-01-18 2008-02-14 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
CA2646539A1 (en) 2006-03-23 2007-09-27 Novartis Ag Imidazoquinoxaline compounds as immunomodulators
GB0713880D0 (en) 2007-07-17 2007-08-29 Novartis Ag Conjugate purification
WO2009034473A2 (en) 2007-09-12 2009-03-19 Novartis Ag Gas57 mutant antigens and gas57 antibodies
NZ601543A (en) 2007-12-21 2013-03-28 Novartis Ag Mutant forms of streptolysin o
SI2268618T1 (en) 2008-03-03 2015-09-30 Novartis Ag Compounds and compositions as tlr activity modulators
NZ594029A (en) 2009-01-12 2014-01-31 Novartis Ag Cna_b domain antigens in vaccines against gram positive bacteria
WO2010144734A1 (en) 2009-06-10 2010-12-16 Novartis Ag Benzonaphthyridine-containing vaccines
EP2443250B8 (en) 2009-06-16 2016-09-21 GlaxoSmithKline Biologicals SA High-throughput complement-mediated antibody-dependent and opsonic bactericidal assays
JO3257B1 (en) 2009-09-02 2018-09-16 Novartis Ag Compounds and compositions as tlr activity modulators
AU2010290896B2 (en) 2009-09-02 2014-07-03 Glaxosmithkline Biologicals S.A. Immunogenic compositions including TLR activity modulators
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
SG181712A1 (en) 2009-12-15 2012-07-30 Novartis Ag Homogeneous suspension of immunopotentiating compounds and uses thereof
CA2792938C (en) 2010-03-23 2018-07-31 Irm Llc Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc.
JP2013532008A (en) 2010-05-28 2013-08-15 テトリス オンライン インコーポレイテッド Interactive hybrid asynchronous computer game infrastructure
US9192661B2 (en) 2010-07-06 2015-11-24 Novartis Ag Delivery of self-replicating RNA using biodegradable polymer particles
ES2670863T3 (en) 2013-02-01 2018-06-01 Glaxosmithkline Biologicals Sa Intradermal administration of immunological compositions comprising Toll-like receptor agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712118A (en) * 1993-09-29 1998-01-27 Research Foundation Of State University Of New York Vaccine for branhamella catarrhalis
US5607846A (en) * 1994-05-17 1997-03-04 Research Foundation Of State University Of New York Vaccine for moraxella catarrhalis
US7341727B1 (en) * 1996-05-03 2008-03-11 Emergent Product Development Gaithersburg Inc. M. catarrhalis outer membrane protein-106 polypeptide, methods of eliciting an immune response comprising same
US6004562A (en) * 1996-08-16 1999-12-21 The Research Foundation Of The State University Of New York Outer membrane protein B1 of Moraxella catarrhalis

Also Published As

Publication number Publication date
AU4260199A (en) 1999-11-29
WO1999058562A3 (en) 2001-05-17
CA2328061A1 (en) 1999-11-18
WO1999058562A2 (en) 1999-11-18
EP1086127A1 (en) 2001-03-28

Similar Documents

Publication Publication Date Title
GB9818731D0 (en) Compounds
PL353156A1 (en) Compounds
GB9804734D0 (en) Compounds
GB9819847D0 (en) Novel compounds
GB9803411D0 (en) Novel compounds
GB9801392D0 (en) Novel compounds
IES81166B2 (en) Novel compound
GB9804175D0 (en) Compounds
GB9808327D0 (en) Antidiotypic compounds
GB9819681D0 (en) Novel compounds
GB9815163D0 (en) Compounds
GB9810193D0 (en) Novel compounds
GB9816984D0 (en) Novel compounds
GB9922519D0 (en) Compounds
GB9810276D0 (en) Novel compounds
GB9808866D0 (en) Novel compounds
GB9826941D0 (en) Compounds
GB9922521D0 (en) Compounds
GB9818689D0 (en) Compounds
GB9808734D0 (en) Novel compounds
IL139955D0 (en) Lantithrombotic compounds
GB9825554D0 (en) Novel Compounds
GB9818881D0 (en) Compounds
GB9828419D0 (en) Novel compounds
GB9822241D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)